Skip to content

Evaluation of perioperative pregabalin for prevention and attenuation of postoperative shoulder pain after thoracotomy in patients with lung cancer

Evaluation of perioperative pregabalin for prevention and attenuation of postoperative shoulder pain after thoracotomy in patients with lung cancer - Evaluation of perioperative pregabalin for prevention and attenuation of postoperative shoulder pain after thoracotomy in patients with lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014515
Enrollment
40
Registered
2014-07-09
Start date
2012-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer Neuropathic Pain Postoperative shoulder pain

Interventions

Patients received pregabalin 150 mg po 10-16 h after surgery and then non-steroidal anti-inflammatory drugs (NSAIDs) po 2 hours later. (maximum dose is 300 mg/day) only NSAIDs po (loxoprofen 180mg/da

Sponsors

Akita University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Histologically or cytologically confirmed lung cancer 2)without indication for curative radiation therapy 3)Performance Status(ECOG) 0-1 4)Patients aged 20 years or older 5)Sufficient function of main organ and normal hematopoietic function, normal liver function and normal renal function filled the following criteria *Leukocyte counts >= 3,000/mm3 *Neutrophil counts >= 1,500/mm3 *Platelets >= 100,000/mm3 *Hemoglobin concentration >= 9.0 g/dL *AST and ALT, x 2.5 of upper limit of normal (ULN) or less. *Total bilirubin <=1.5mg/dL. *Serum creatinin, x 1.5 of ULN or less. *Electrocardiogram Nomal *SpO2 >=90% or SaPO2 >=65mmHg *Protein urea >= 1+ 6)Patients providing written informed consent

Exclusion criteria

Exclusion criteria: Inappropriate patients for this study judged by the physicians

Design outcomes

Primary

MeasureTime frame
Shoulder pain severity was measured using a 100-mm visual analog scale (VAS) scoring system until post operative days 7.

Countries

Japan

Contacts

Public ContactKazuhiro Imai

Akita University Graduate School of Medicine General Thoracic Surgery (and Breast & Endocrine Surgery)

i-karo@mui.biglobe.ne.jp018-884-6132

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026